In terms of market position of foreign enterprises in China, in 2009, there were more than 250 foreign enterprises above designated size engaged in the pharmaceutical & medicine industry, accounting for more than 20% of all pharmaceutical & medicine enterprises above designated size across China. All foreign pharmaceutical & medicine enterprises achieved a profit of more than RMB 10 billion in all, accounting for more than 45% of the total profit in this industry.

In terms of industry profit, in 2009, enterprises above designated size in pharmaceutical & medicine industry across China achieved a profit of more than RMB 25 billion in all, a growth of more than 20% on a year-on-year basis. In 2009, more than 250 enterprises in this industry suffered a loss. The industry average of the rate of return on assets was higher than 10%, and the rate of return on net assets was higher than 15%.

In terms of pharmaceutical & medicine import and export, in 2010, the value of imported pharmaceutical & medicine products in China was more than USD 5 billion, and Germany, Italy and USA ranked top 3 as Origin of Imported Goods, imports from these top three origins added up to USD 2.1 billion, accounting for more than 35% of the gross imports. Shanghai, Beijing and Jiangsu ranked top 3 domestic destinations in imports, and the value of imports in these three regions added up to USD 3.1 billion, accounting for more than 55% of the gross imports across China. In 2010, the gross export of pharmaceutical & medicine products exceeded USD 900 million, Jiangsu, Shanghai and Hebei ranked top 3 as domestic origins, exports from these origins added up to USD 435.2 million, accounting for more than 45% of the gross export across China.